1-1 of 1
Xavier Jacq, PhD
Close
Sort by
Journal Articles

UCHL1 Is a New Therapeutic Target in Lymphoid Malignancies, Independent of ATM and TP53 status

Edward Smith, MSc, Angelo Agathanggelou, PhD, Guy Pratt, MDPhD, Paul Moss, Wenbin Wei, PhD, Leanine Harrigan, Xavier Jacq, PhD, Tatjana Stankovic
Journal: Blood
Blood (2015) 126 (23): 1746.
https://doi.org/10.1182/blood.V126.23.1746.1746
Published: 2015